Every quarter that a customer delays going live with Oracle software is a quarter that Oracle itself waits to book the revenue tied to that contract.
That financial reality has pushed Oracle (NYSE: ORCL) to hand one of its most time-consuming processes over to artificial intelligence agents, in a move announced at its AI World conference in Las Vegas on October 26.
The company unveiled a public registry of setup instructions that AI agents can follow to configure its Fusion business software suite, with agents from OpenAI and other providers able to run and test configurations.
Human specialists retain final authority, reviewing completed setups and granting approval before any system goes live, Oracle said.
The initiative follows a notably candid moment on Oracle’s September 10 earnings call, when CEO Mike Sicilia acknowledged the scale of the problem the company is now trying to solve.
Sicilia spoke of “compressing SaaS deployments from years to months and months to weeks,” an admission that Oracle’s own enterprise software products can take multiple years before a paying customer actually uses them.
Responding to a question from Jefferies analyst Brent Thill, Sicilia made the revenue link explicit, noting that deals in complex industries only ramp up once customers go live, making faster deployments directly valuable to Oracle’s income statement.
Healthcare has been among the worst-affected verticals, with Sicilia noting that some rollouts in the sector stretched into high-double-digit total months before completion.
Lexington Health offered concrete evidence of what AI-assisted configuration can change, with Tom Tan, executive director of IT Business Services, stating the approach “has allowed us to reduce certain design and configuration efforts by 80 percent.”
Tan said he expects further gains as Lexington Health moves through testing and toward full deployment, signaling that the efficiency improvements are not limited to initial configuration work alone.
Wall Street has taken a broadly positive view of Oracle’s direction, with 43 analysts tracked by StockAnalysis collectively assigning the stock a Buy rating and an average price target of $236.54.
One outstanding concern tempers the optimism, however, as CFO Hilary Maxson declined during the September 10 earnings call to specify when Oracle expects to reach positive free cash flow.
Faster deployment cycles may strengthen Oracle’s software revenue trajectory, but the unresolved cash flow timeline means investors are still waiting on a key piece of the financial picture.
